“…In addition, they discussed whether lysoGb3 may play a role in disease progression, but molecular mechanisms or clinical consequences are currently unclear. LysoGb3 enhances toxicity of the viper venom verotoxin 2, a protein which binds to the natural membrane-anchored Gb3 receptor [24], and Gb3 levels in fibroblasts were increased upon addition of lysoGb3 [23]. This indicates that lysoGb3 may inhibit the key enzyme ␣-galactosidase, but this could not be confirmed up to now [25].…”